RESEARCHER PROFILE
Rainer R. Haas
← Back to Heinrich Heine University Düsseldorf
R
Heinrich Heine University Düsseldorf
Rainer R. Haas works in Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Multiple Myeloma Research and Treatments, Mesenchymal stem cell research. Recorded institutional associations include Düsseldorf University Hospital, Heinrich Heine University Düsseldorf.
565Publications
15,158Citations
67H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
1994 · 470 citationsTreatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
2004 · 255 citationsInsufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
2013 · 238 citationsAzacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
2013 · 225 citationsThe histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
2005 · 224 citationsSuccessful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
1990 · 217 citationsIncidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry
2011 · 206 citationsThe monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
2008 · 193 citationsTreatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
2014 · 192 citationsPhase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
2004 · 169 citationsRefinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
2005 · 162 citationsAcute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner
2016 · 155 citationsProspective validation of the WHO proposals for the classification of myelodysplastic syndromes.
2006 · 154 citationsResults of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia
2005 · 154 citationsFunctional inhibition of mesenchymal stromal cells in acute myeloid leukemia
2015 · 151 citationsThalidomide for the treatment of patients with myelodysplastic syndromes
2002 · 150 citationsGene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells
2002 · 148 citationsMolecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase
2007 · 148 citationsFast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR
2002 · 144 citationsSuccessful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
1993 · 137 citationsTumor immune escape by the loss of homeostatic chemokine expression
2007 · 133 citationsTreatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody
2001 · 133 citationsPrimary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators
2004 · 129 citationsImproved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
2012 · 126 citationsSurvival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study
2012 · 126 citations
